Alphavirus Replicon Particles Expressing TRP-2 Provide Potent Therapeutic Effect on Melanoma through Activation of Humoral and Cellular Immunity (Q28749317)

From Wikidata

Jump to navigation Jump to search

scientific article (publication date: 10 September 2010)

Language	Label	Description	Also known as
English	Alphavirus Replicon Particles Expressing TRP-2 Provide Potent Therapeutic Effect on Melanoma through Activation of Humoral and Cellular Immunity	scientific article (publication date: 10 September 2010)

Statements

scholarly article

0 references

Alphavirus replicon particles expressing TRP-2 provide potent therapeutic effect on melanoma through activation of humoral and cellular immunity (English)

0 references

Alphavirus Replicon Particles Expressing TRP-2 Provide Potent Therapeutic Effect on Melanoma through Activation of Humoral and Cellular Immunity (English)

1 reference

10.1371/JOURNAL.PONE.0012670

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0012670

14 July 2024

cell-mediated immunity

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20844763

14 July 2024

humoral immunity

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20844763

14 July 2024

Jedd D. Wolchok

9

object named as

Jedd D Wolchok

0 references

2

object named as

Taha Merghoub

0 references

author name string

Francesca Avogadri

1

0 references

Daniel Hirschhorn-Cymerman

4

0 references

John Morris

5

0 references

Erika Ritter

6

0 references

Robert Olmsted

7

0 references

Maureen F. Maughan

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20844763

14 July 2024

Alan N. Houghton

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20844763

14 July 2024

language of work or name

0 references

publication date

10 September 2010

0 references

full work available at URL

https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0012670&type=printable

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20844763

14 July 2024

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20844763/pdf/?tool=EBI

Portable Document Format

online access status

content deliverer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20844763

14 July 2024

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20844763/?tool=EBI

online access status

content deliverer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20844763

14 July 2024

https://europepmc.org/articles/PMC2937034

online access status

content deliverer

Europe PubMed Central

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20844763

14 July 2024

https://europepmc.org/articles/PMC2937034?pdf=render

Portable Document Format

online access status

content deliverer

Europe PubMed Central

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20844763

14 July 2024

http://dx.plos.org/10.1371/journal.pone.0012670

1 reference

10.1371/JOURNAL.PONE.0012670

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0012670

14 July 2024

0 references

5

0 references

9

0 references

e12670

0 references

copyright license

Creative Commons Attribution 4.0 International

10 September 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Activation of MDA5 requires higher-order RNA structures generated during virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937034

16 March 2017

Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937034

16 March 2017

Natural selection of tumor variants in the generation of "tumor escape" phenotypes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937034

16 March 2017

Cancer immunoediting: from immunosurveillance to tumor escape

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937034

16 March 2017

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937034

16 March 2017

Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937034

16 March 2017

Correlation of clinical and immunological data in a metastatic melanoma patient with heterogeneous tumor responses to ipilimumab therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937034

3 June 2018

Mouse models for melanoma: a personal perspective

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937034

3 June 2018

New insights into the active site structure and catalytic mechanism of tyrosinase and its related proteins.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937034

3 June 2018

High-avidity autoreactive CD4+ T cells induce host CTL, overcome T(regs) and mediate tumor destruction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937034

3 June 2018

Type 17 CD8+ T cells display enhanced antitumor immunity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937034

3 June 2018

Monoclonal antibodies for cancer immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937034

3 June 2018

Role of TLR3 in the immunogenicity of replicon plasmid-based vaccines.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937034

3 June 2018

Improved tumor immunity using anti-tyrosinase related protein-1 monoclonal antibody combined with DNA vaccines in murine melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937034

3 June 2018

Development and preclinical evaluation of an alphavirus replicon particle vaccine for cytomegalovirus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937034

3 June 2018

The regulation of skin pigmentation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937034

3 June 2018

Unraveling the complex relationship between cancer immunity and autoimmunity: lessons from melanoma and vitiligo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937034

3 June 2018

Type I Interferons are essential for the efficacy of replicase-based DNA vaccines.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937034

3 June 2018

Recombinant alphaviruses as vectors for anti-tumour and anti-microbial immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937034

3 June 2018

Comparison of two cancer vaccines targeting tyrosinase: plasmid DNA and recombinant alphavirus replicon particles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937034

3 June 2018

Efficient expansion of HIV-1-specific T cell responses by homologous immunization with recombinant Semliki Forest virus particles.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937034

3 June 2018

Mutations in dopachrome tautomerase (Dct) affect eumelanin/pheomelanin synthesis, but do not affect intracellular trafficking of the mutant protein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937034

3 June 2018

MyD88 expression is required for efficient cross-presentation of viral antigens from infected cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937034

3 June 2018

Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937034

3 June 2018

Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: implications for tumor immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937034

3 June 2018

Recombinant Semliki Forest virus particles expressing louping ill virus antigens induce a better protective response than plasmid-based DNA vaccines or an inactivated whole particle vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937034

3 June 2018

Genetic vaccination with "self" tyrosinase-related protein 2 causes melanoma eradication but not vitiligo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937034

3 June 2018

Induction of P815 tumor immunity by recombinant Semliki Forest virus expressing the P1A gene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937034

3 June 2018

Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937034

3 June 2018

Tumor immunity and autoimmunity induced by immunization with homologous DNA

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937034

3 June 2018

Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937034

3 June 2018

The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937034

3 June 2018

Functional analysis of the slaty gene product (TRP2) as dopachrome tautomerase and the effect of a point mutation on its catalytic function.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937034

3 June 2018

Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937034

3 June 2018

Implicating a role for immune recognition of self in tumor rejection: passive immunization against the brown locus protein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937034

3 June 2018

Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937034

3 June 2018

Functional Properties of Cloned Melanogenic Proteins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937034

3 June 2018

TRP-2/DT, a new early melanoblast marker, shows that steel growth factor (c-kit ligand) is a survival factor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937034

3 June 2018

Inhibition of angiogenesis by a Semliki Forest virus vector expressing VEGFR-2 reduces tumour growth and metastasis in mice.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012670

21 January 2018

Venezuelan equine encephalitis replicon immunization overcomes intrinsic tolerance and elicits effective anti-tumor immunity to the 'self' tumor-associated antigen, neu in a rat mammary tumor model

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012670

21 January 2018

Induction of specific human primary immune responses to a Semliki Forest virus-based tumor vaccine in a Trimera mouse model

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012670

21 January 2018

Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012670

21 January 2018

A novel alphavirus vaccine encoding prostate-specific membrane antigen elicits potent cellular and humoral immune responses

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012670

21 January 2018

Autoimmunity and tumor immunity induced by immune responses to mutations in self

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012670

21 January 2018

The Inhibition of Early N-Glycan Processing Targets TRP-2 to Degradation in B16 Melanoma Cells

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012670

21 January 2018

Antibody responses to melanoma/melanocyte autoantigens in melanoma patients

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012670

21 January 2018

Experimental Antibody Therapy of Liver Metastases Reveals Functional Redundancy between Fc RI and Fc RIV

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012670

21 January 2018

Genetic immunization of mice with human tyrosinase-related protein 2: implications for the immunotherapy of melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20844763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mac-1 (CD11b/CD18) is crucial for effective Fc receptor-mediated immunity to melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20844763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increase in melanin formation and promotion of cytotoxicity in cultured melanoma cells caused by phosphorylated isomers of L-dopa

1 reference

https://pubmed.ncbi.nlm.nih.gov/20844763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0012670

0 references

2010PLoSO...512670A

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28749317&oldid=2210137900"